Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBilici, Ahmet
dc.contributor.authorUysal, Mukremin
dc.contributor.authorMenekse, Serkan
dc.contributor.authorAkin, Semih
dc.contributor.authorYildiz, Fatih
dc.contributor.authorTuran, Merve
dc.contributor.authorSezgin Goksu, Sema
dc.contributor.authorBeypinar, Ismail
dc.contributor.authorSakalar, Teoman
dc.contributor.authorDegirmenci, Mustafa
dc.contributor.authorErdem, Dilek
dc.contributor.authorBasaran, Gul
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorAvci, Nilufer
dc.contributor.authorTural, Deniz
dc.contributor.authorSakin, Abdullah
dc.contributor.authorTurker, Sema
dc.contributor.authorDemir, Atakan
dc.contributor.authorTemiz, Suleyman
dc.contributor.authorKaplan, Muhammed Ali
dc.contributor.authorDogan, Mutlu
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorBilgetekin, Irem
dc.contributor.authorCinkir, Havva Yesil
dc.contributor.authorAcikgoz, Ozgur
dc.contributor.authorPaydas, Semra
dc.contributor.authorUslu, Ruchan
dc.contributor.authorTurhal, Serdar
dc.date.accessioned2025-10-16T15:18:13Z
dc.date.issued2022
dc.identifier.doi10.1080/07357907.2021.2017952
dc.identifier.otherWOS:000734258300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7100
dc.publisherTAYLOR \& FRANCIS INC
dc.sourceCANCER INVESTIGATION
dc.subjectEverolimus
dc.subjectexemestane
dc.subjectmetastatic breast cancer
dc.subjecthormone receptor\\-positive
dc.subjectHER \\- negative
dc.subjectefficacy
dc.titleReal-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS